Manatuck Hill Partners, LLC Celcuity Inc. Transaction History

Manatuck Hill Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.96 - $19.35 $402,394 - $651,030	-33,645 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.35 - $24.87 $309,784 - $444,053	-17,855 Reduced 34.67%	33,645 $606,000
Q1 2021 May 14, 2021	BUY	$10.43 - $17.8 $537,145 - $916,700	51,500 New	51,500 $739,000
Q3 2018 Nov 14, 2018	SELL	$20.96 - $30.77 $569,378 - $835,867	-27,165 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.13 - $26.99 $1.17 Million - $1.96 Million	-72,435 Reduced 72.73%	27,165 $674,000
Q1 2018 May 15, 2018	SELL	$13.55 - $21.3 $344,170 - $541,020	-25,400 Reduced 20.32%	99,600 $1.64 Million
Q3 2017 Nov 14, 2017	BUY	$11.94 - $14.29 $1.49 Million - $1.79 Million	125,000	125,000 $1.53 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $190M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Manatuck Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Manatuck Hill Partners, LLC with notifications on news.